Browse All

Current Filters

CLEAR FILTER x

TITLE

Characteristics and Treatment Response to OnabotulinumtoxinA of Patients From CD-PROBE With Anterocollis and Retrocollis

Author:Dashtipour, Khashayar   Jankovic, Joseph   Charles, David   Mehta, Shyamal   Schwartz, Marc   Sadeghi, Marjan   

Session Name:P12: Movement Disorders: Dystonia 2  

Topic:Movement Disorders  

Program Number:P12.005  

Author Institution:Loma Linda University, Loma Linda, CA  Baylor College of Medicine, Houston, TX  Vanderbilt University Medical Center, Nashville, TN  Mayo Clinic, Arizona, Phoenix, AZ  MS Biostatistics, LLC, Clermont, FL  Abbvie/Allergan, Irvine, CA  

Treating Upper Limb Spasticity With OnabotulinumtoxinA: Subgroup Analysis of US Practice Patterns From the ASPIRE Study

Author:Francisco, Gerard   Feng, Wayne   Munin, Michael   Ngo, Kenneth   Schwartz, Marc   Sadeghi, Marjan   Zuzek, Aleksej   Esquenazi, Alberto   

Session Name:P12: Neuro-rehabilitation  

Topic:Neuro-rehabilitation  

Program Number:P12.012  

Author Institution:University of Texas McGovern Medical School and TIRR Memorial Hermann, Houston, TX  Duke University School of Medicine, Durham, NC  University of Pittsburgh School of Medicine, Pittsburgh, PA  Brooks Rehabilitation Hospital, Jacksonville, FL  MS Biostatistics, LLC, Clermont, FL  AbbVie/Allergan, Los Angeles, CA  Abbvie/Allergan, Irvine, CA  MossRehab Gait and Motion Analysis Laboratory, Elkins Park, PA  

Real-World Clinical Utilization Differences of onabotulinumtoxinA and abobotulinumtoxinA in Upper Limb Spasticity

Author:Nelson, Mariana   Zuzek, Aleksej   Schwartz, Marc   Singh, Ritu   

Session Name:P12: Neuro-rehabilitation  

Topic:Neuro-rehabilitation  

Program Number:P12.013  

Author Institution:AbbVie, Irvine, CA  MS Biostatistics LLC, Clermont, FL